Naturally occurring polymorphisms that reduce NQO1 expression are associated with higher rates of solid tumors [46], [47], [48], poor survival in breast cancer [49] and carotid artery plaques in type II diabetes [50]. This evidence concerns the gene NQO1 and type 2 diabetes mellitus.